NRX Pharmaceuticals Inc
Biotechnology
Healthcare
NRXP
16.41 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.87
52 week high
5.10
high
2.94
52 week low
0.00
low
2.81
growth
74.85 %
previous Close
2.87
P/E ratio
market cap
48.86 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-17.58 M
-218.96 %
eps
0.00 %
-188.24 %
eps surprise
-326.09 %
net profit margin
-1758100000.00 %
1378.00 %
operating incoming
-3.73 M
3.04 %
net change in cash
-2.64 M
-164.26 %
cash on hand
2.91 M
-47.55 %
cost of revenue
0.00 %
top top